Results for Pediatric Obesity

Dr. Prout is a nutrition pediatrician, an academic investigator in the Healthy Weight Program at Children's Hospital of Philadelphia, and an assistant professor of pediatrics at the University of Pennsylvania. Her research focuses on childhood obesity.

Dr. Xanthopoulos's research focuses on the development, implementation, and adherence to medical and lifestyle interventions, including non-invasive ventilation (CPAP/BPAP), eating habits, physical activity, and sleep. She has a particular interest in the interactions among behavioral, lifestyle, psychosocial and physiologic factors as they relate to health and neurobehavioral functioning and quality of life in youth and families.

Dr. Berger's research focus involves the development of pediatric heart failure and underlying metabolic drivers. He studies how improving metabolic dysregulation may also benefit cardiac dysfunction.

The overarching goal of my research is to help prevent chronic diseases in later life, by focusing on energetic behaviors (sleep, diet, and physical activity) and their impact on body composition during growth and development.

Dr. Henrickson investigates the mechanisms of T cell dysfunction in monogenic primary immunodeficiency and chronic inflammatory disease, including asthma and obesity, and primary immunodeficiency.

Dr. Pinney investigates the molecular mechanisms that link an adverse intrauterine milieu to the development of diabetes and obesity later in life. Specifically, she is researching how intrauterine growth restriction, gestational diabetes and in utero exposure to environmental toxicants contribute to the development of diabetes and obesity in offspring.

Dr. Roizen's research program aims to understand non-calciometabolic effects of vitamin D and to use this understanding to design new therapeutic approaches to common diseases such as sarcopenia and obesity.

Dr. Shah's research is centered on understanding obesity and its related complications. Her current work includes clinical and translational studies exploring pathophysiology and modulation of obesity-related adipose tissue and systemic inflammation using human cell lines and clinical trials. She is also involved in clinical studies of outcomes and risk factors of polycystic ovarian syndrome and type 2 diabetes in teens.

Dr. Stallings is working on intervention trials involving three chronic diseases with nutrition-related abnormalities resulting in meaningful adverse outcomes: cystic fibrosis (new drugs), sickle cell disease (vitamin A) and chronic pancreatitis (enzyme replacement drug).

Dr. Mayne is an epidemiologist whose research focuses on preventing cardiovascular disease and promoting healthy behaviors in children and their families. She employs multilevel and longitudinal methods to study how factors at the individual, family, neighborhood, and policy level influence risk factor behaviors and cardiometabolic outcomes. She is also engaged in research to promote innovation in pediatric primary care.